Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2025

Genmab — Januar 2025

Planlagt Fastgjort Låst Flyttet Genmab
702 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • L Offline
    L Offline
    lahn1
    wrote on sidst redigeret af
    #423

    Er Carvykti grundt til lidt skuffenede Dara salg i Q4 ?

    1 Reply Last reply
    0
    • SolsenS Offline
      SolsenS Offline
      Solsen
      wrote on sidst redigeret af
      #424

      Vand på erzo møllen

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #425

        Godmorgen 🙂

        1 Reply Last reply
        0
        • L Offline
          L Offline
          LP90
          wrote on sidst redigeret af
          #426

          Godmorgen 🙂

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Stroka
            wrote on sidst redigeret af
            #427

            God morgen 🙂

            1 Reply Last reply
            0
            • P Offline
              P Offline
              ProinvestorNEWS
              wrote on sidst redigeret af
              #428

              Genmab får sakset 15 pct. af kursmålet hos amerikansk børshus https://proinvestor.com/investornyt/1268962/genmab-far-sakset-15-pct-af-kursmalet-hos-amerikansk-borshus

              1 Reply Last reply
              0
              • M Offline
                M Offline
                mobbyduck1
                wrote on sidst redigeret af
                #429

                det ligner et hak i tuden i dag, desværre....

                1 Reply Last reply
                0
                • J Offline
                  J Offline
                  JKY_VH
                  wrote on sidst redigeret af
                  #430

                  Ja GS føler åbenbart trang til at lukke en "bæ" ud. Jeg synes ikke umiddelbart at der er nogen forklaring bortset fra usikkerhed omkring Hexa og det er jo ingen nyhed.

                  1 Reply Last reply
                  0
                  • M Offline
                    M Offline
                    mobbyduck1
                    wrote on sidst redigeret af
                    #431

                    genmab er så billig, at man får alt gratis, hvis man trækker Darzalex og egenkapital fra. Det er helt til grin

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #432

                      New Mount Sinai Trial Reveals Major Advance in Treatment of Aggressive Lymphoma https://www.mountsinai.org/about/newsroom/2025/new-mount-sinai-trial-reveals-major-advance-in-treatment-of-aggressive-lymphoma

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #433

                        Danish biotech Genmab (CPH: GMAB) today announced it has named Leslie Amendola senior vice president and general manager of its US business. https://www.thepharmaletter.com/genmab-names-us-general-manager https://www.linkedin.com/posts/genmab_newsupdate-activity-7288199613231120386-i8xM/

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #434

                          Godmorgen 🙂

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #435

                            why would Genmab sponsor anything for hemophilia care? https://www.surveymonkey.com/r/H7HFWZ5 (could it have something to do with bleeding side effects from Tisotumab?)( i am assuming it is not related to Hemab, why would it go via Genmab
                            )

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #436

                              Brian Slomovitz, MD, MS, FACOG
                              @GynCancerMD

                              Honored to discuss our practice changing study using tisotumab vedotin in patients recurrent cervical cancer. Led to full FDA approval https://x.com/GynCancerMD/status/1882780591390921153 -Podcast

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #437

                                Bichoy Gabra, R.Ph., Ph.D.
                                @BichoyGabra
                                Tivdak (tisotumab vedotin-tftv) mechanism of action in metastatic cervical cancer https://x.com/BichoyGabra/status/1881714400291168285

                                1 Reply Last reply
                                0
                                • L Offline
                                  L Offline
                                  lahn1
                                  wrote on sidst redigeret af
                                  #438

                                  Hmm that interesting noting relevant in the pileline so could be bleeding issue with TV. Did we see any bleeding issues in Rina-s ?

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    gentogen
                                    wrote on sidst redigeret af
                                    #439

                                    In innovaTV 204, TRAEs of bleeding occurred in 39 patients (39%) and were mostly grades 1 or 2;

                                    1 Reply Last reply
                                    0
                                    • G Offline
                                      G Offline
                                      gentogen
                                      wrote on sidst redigeret af
                                      #440

                                      Checking your browser - reCAPTCHA

                                      favicon

                                      (pmc.ncbi.nlm.nih.gov)

                                      1 Reply Last reply
                                      0
                                      • Y Offline
                                        Y Offline
                                        YPE
                                        wrote on sidst redigeret af
                                        #441

                                        God morgen.. Nogen der kan genopfriske, hvilke taktiske årsager jnj kan have for ikke at tage optionen, hvis data er super gode?

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #442

                                          De har jo allerede Darzalex FasPro 5 år længere, så de har jo den overvejende indtægt på plads uden at skulle betale royalty til Genmab.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper